TTOO

Stats

Summary

t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www

Market Cap: 23.8 Million

Primary Exchange: NASDAQ

Website: http://www.t2biosystems.com/

Shares Outstanding: 4.93 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.01801448339745

Sector: Manufacturing

Industry: Small Arms, Ordnance, and Ordnance Accessories Manufacturing

Ethical Flags

Longest drawdown: 1866 trading days

From: 2015-01-14 To: 2024-03-07

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor